EGFR Mutations in Lung Cancer in Northern Mexican Population

被引：0
|
作者：
Lopez Resendiz, K. E. [1 ]
Barboza Quintana, O. [1 ]
Garza Guajardo, R. [1 ]
Vilches Cisneros, N. [1 ]
Flores Gutierrez, J. P. [1 ]
机构：
[1] Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
Non-small cell lung cancer; Mutation; EGFR; MX;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01
引用
收藏
页码：S1174 / S1174
页数：1
相关论文
共 50 条
  • [21] Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer
    Yufeng Li
    Tianyu Mao
    Jing Wang
    Hongrui Zheng
    Ziyi Hu
    Pingping Cao
    Suisui Yang
    Lingyun Zhu
    Shunyao Guo
    Xinfei Zhao
    Yue Tian
    Hua Shen
    Fan Lin
    Cell Communication and Signaling, 21
  • [22] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    A F Gazdar
    Oncogene, 2009, 28 : S24 - S31
  • [23] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    Gazdar, A. F.
    ONCOGENE, 2009, 28 : S24 - S31
  • [24] LUNG CANCER BIOMARKER 2 (EGFR)
    Dacic, Sanja
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S441 - S441
  • [25] Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer
    Li, Yufeng
    Mao, Tianyu
    Wang, Jing
    Zheng, Hongrui
    Hu, Ziyi
    Cao, Pingping
    Yang, Suisui
    Zhu, Lingyun
    Guo, Shunyao
    Zhao, Xinfei
    Tian, Yue
    Shen, Hua
    Lin, Fan
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
  • [26] Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer
    Lim, Ken-Hong
    Huang, Ming-Jer
    Liu, Hung-Chang
    Kuo, Hsu-Tah
    Tzen, Chin-Yuan
    Hsieh, Ruey-Kuen
    MEDICAL ONCOLOGY, 2007, 24 (04) : 388 - 393
  • [27] Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer
    Ken-Hong Lim
    Ming-Jer Huang
    Hung-Chang Liu
    Hsu-Tah Kuo
    Chin-Yuan Tzen
    Ruey-Kuen Hsieh
    Medical Oncology, 2007, 24 : 388 - 393
  • [28] Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNuM)
    Janning, M.
    Sueptitz, J.
    Albers-Leischner, C.
    Delpy, P.
    Tufman, A.
    Velthaus-Rusik, J-L
    Reck, M.
    Jung, A.
    Kauffmann-Guerrero, D.
    Bonzheim, I
    Braendlein, S.
    Hummel, H-D
    Wiesweg, M.
    Schildhaus, H-U
    Stratmann, J. A.
    Sebastian, M.
    Alt, J.
    Buth, J.
    Esposito, I
    Berger, J.
    Toegel, L.
    Saalfeld, F. C.
    Wermke, M.
    Merkelbach-Bruse, S.
    Hillmer, A. M.
    Klauschen, F.
    Bokemeyer, C.
    Buettner, R.
    Wolf, J.
    Loges, S.
    ANNALS OF ONCOLOGY, 2022, 33 (06) : 602 - 615
  • [29] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Sema Bircan
    Huseyin Baloglu
    Zafer Kucukodaci
    Ahmet Bircan
    Medical Oncology, 2014, 31
  • [30] Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer
    Sriram, K. B.
    Tan, M. E.
    Savarimuthu, S. M.
    Wright, C. M.
    Relan, V.
    Stockwell, R. E.
    Clarke, B. E.
    Duhig, E. E.
    Yang, I. A.
    Bowman, R. V.
    Fong, K. M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (04) : 903 - 910
12345